Accelerate Cancer Treatment with Avitia
Innovate Cancer Testing Solutions for Lasting Impact
Frequently Asked Questions
Avitia creates modular and cost-effective molecular testing oncology solutions that improve patient outcomes. We empower labs and clinicians with innovative diagnostics that reduce costs and improve access to personalized treatments.
Avitia’s end-to-end platform solution seamlessly integrates into any lab, rapidly providing advanced bioinformatics and personalized treatment planning. This empowers clinical labs and oncologists to perform on-site precision diagnostics, accelerating patient management.
Avitia’s NGS-based molecular tests are tailored for clinical and research applications. Our targeted tissue and liquid biopsy panels are robust performing — ensuring patient tumor testing results are accurate, actionable, as well as timely. Additionally, Avitia’s streamlined processes and advanced technology are built to integrate with comprehensive tests like CGP and low-pass whole genome. This provides labs and oncologists with diagnostic flexibility, as well as operational efficiency.
Avitia offers comprehensive end-to-end support, including lab setup consulting, regulatory compliance, and technical guidance. The modular systems enable partners to deliver high-quality diagnostics, and we empower local clinicians with advanced insights.
With the solution utilizing widely available materials and a modular technology system, Avitia eliminates the need for proprietary testing kits and supports equipment flexibility — reducing costs without compromising quality. This ensures accessibility to high-quality NGS testing solutions for labs of all sizes — even in underserved regions.
Avitia is transforming global oncology diagnostics by creating modular, scalable, and cost-effective solutions that allow targeted treatments for better patient outcomes. By targeting cancer with precision, Avitia puts time back on the patients’ side and reduces the need for unnecessary procedures and treatments.